To explore the association between TLR-4 and p38 signaling in mediating thrombin-dependent endothelial inflammation, we employed pharmacological inhibitors of TLR-4 and p38, and then measured their effects on each other signaling pathway activation, respectively. This evidence concerns the gene TLR4 and inflammation.